Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1676
    +0.0020 (+0.17%)
     

  • GBP/USD

    1.2495
    -0.0016 (-0.13%)
     

  • Bitcoin GBP

    51,112.93
    -585.34 (-1.13%)
     

  • CMC Crypto 200

    1,330.97
    -65.56 (-4.69%)
     

  • S&P 500

    5,108.37
    +59.95 (+1.19%)
     

  • DOW

    38,290.50
    +204.70 (+0.54%)
     

  • CRUDE OIL

    83.64
    +0.07 (+0.08%)
     

  • GOLD FUTURES

    2,349.00
    +6.50 (+0.28%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Germany plans to extend price brake for drugs under statutory insurance

Reuters - UK Focus

BERLIN, July 25 (Reuters) - Germany wants to extend a price brake for drugs covered by statutory health insurance for five years beyond 2017, stretching out the measure introduced in 2009, a draft law seen by Reuters shows.

The health ministry estimates savings from the extension will amount to between 1.5 and 2.0 billion euros ($1.65-2.19 billion), ministry sources said.

Under the draft law, the government in Germany, Europe's biggest market for medicines, also wants to lower prices of newly launched drugs within the first 12 months if sales are greater than 250 million euros. ($1 = 0.9113 euros) (Reporting by Thorsten Severin; Writing by Paul Carrel; Editing by Caroline Copley)